MDxHealth SA SEC filings MDXH

MDxHealth SA has 183 filings in SEC EDGAR's recent list, going back to Aug 9, 2021. Its latest annual report, Form 20-F, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 30, 2026.

Form Description Filed Period
424B5 Prospectus supplement Aug 13, 2026 —
S-8 Employee stock plan registration Apr 3, 2026 —
F-3/A Amendment no.1 to form f-3 Feb 11, 2026 —
F-3 Shelf registration (foreign issuer) Dec 29, 2025 —
424B5 Prospectus supplement Sep 26, 2024 —
424B5 Prospectus supplement Sep 25, 2024 —
F-3/A Amendment no. 1 to form f-3 Jul 3, 2024 —
F-3 Shelf registration (foreign issuer) Jun 28, 2024 —
424B5 Prospectus supplement Apr 30, 2024 —
424B5 Prospectus supplement Feb 6, 2023 —
424B5 Prospectus supplement Feb 1, 2023 —
F-3 Shelf registration (foreign issuer) Dec 19, 2022 —
424B4 Prospectus Nov 5, 2021 —
F-1/A Amendment no. 2 to form f-1 Nov 1, 2021 —
F-1/A Registration statement Oct 28, 2021 —
F-1 Registration statement (foreign issuer) Oct 13, 2021 —

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
MDXH (Nasdaq)
Incorporated in
Belgium
Headquarters
Herstal, Belgium
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1872529

Other Services-Medical Laboratories companies

All 29 Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.